“…5). These include transcription factors such as En1 (Loomis et al, 1996), Dlx2, 5 and6 (Bulfone et al, 1993;Robledo et al, 2002;Kraus and Lufkin, 2006), Msx2 (Davidson et al, 1991), and Sp8, Sp9 and Sp6 (Treichel et al, 2003;Bell et al, 2003;Nakamura et al, 2004); components of signaling pathways such as Bmp2, 4 and 7 (Francis et al, 1994;Lyons et al, 1995) Wnt3a/Wnt3 (Kengaku et al, 1998;Barrow et al, 2003), Notch1, Jag2 and Rfng (Radical fringe; Laufer et al, Sidow et al, 1997;Jiang et al, 1998); the transmembrane protein Flrt3 (Smith and Tickle, 2006) and several epithelial markers such as Cd44 (Wheatley et al, 1993), the connexin Cx43 (Laird et al, 1992), and p63 (Mills et al, 1999;Yang et al, 1999). Several of these mentioned genes are specifically expressed in the AER and can also be considered AER markers (Bell et al, 1998) but others, such as En1, Msx2, Bmps, Sp8, Sp9 and Sp6 exhibit ectodermal domains of expression broader than that of Fgf8.…”